Investment Thesis
SRx Health Solutions exhibits terminal financial distress with operating losses exceeding revenue (-135% operating margin), negative operating cash flow, and unsustainable cash burn. The company is destroying shareholder value (ROE -244%) and faces critical liquidity constraints (current ratio 0.80x) that will exhaust cash reserves within 12-18 months at current burn rates.
Strengths
- Gross margin of 37.5% indicates core product viability if operational overhead could be controlled
- Cash position of $13.1M provides temporary liquidity buffer for restructuring attempts
- Modest insider activity (2 Form 4 filings/90 days) suggests management retention without panic selling
Risks
- Operating loss of $3.8M exceeds total revenue of $2.8M - fundamentally unsustainable economics
- Negative operating cash flow of -$2.9M indicates core business is burning cash, not generating value
- Current ratio 0.80x creates acute liquidity crisis; current assets insufficient to cover current liabilities
- Debt-to-equity ratio of 1.26x combined with negative profitability and cash burn creates imminent default risk
- Revenue base of $2.8M is insufficient to support operating expenses of $6.6M - structural viability question
Key Metrics to Watch
- Operating cash flow - must achieve positive cash generation from operations to survive
- Revenue growth and cost structure - path to gross profit coverage of operating expenses
- Cash runway - months of operations remaining before liquidity depletion at current burn rate
Financial Metrics
Revenue
2.8M
Net Income
-8.6M
EPS (Diluted)
$-0.26
Free Cash Flow
-2.9M
Total Assets
27.1M
Cash
13.1M
Profitability Ratios
Gross Margin
37.5%
Operating Margin
-135.0%
Net Margin
-306.9%
ROE
-244.4%
ROA
-31.8%
FCF Margin
-104.3%
Balance Sheet & Liquidity
Current Ratio
0.80x
Quick Ratio
0.74x
Debt/Equity
1.26x
Debt/Assets
87.0%
Interest Coverage
-6.04x
Long-term Debt
4.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-16T14:36:26.292490 |
Data as of: 2025-12-31 |
Powered by Claude AI